Endonovo Therapeutics Inc (ID) (ENDV)

All of the revenue is now flowing through Sofpulse, Inc. ENDV no longer has any assets, even though it supposedly executed an agreement to sell sofpulse the corresponding asset does not exist on the balance sheet. Collier is a fraud. He fleeced ENDV investors and has now moved on to fleecing a new set of idiots investing in sofpulse at a $100 million valuation.

Q1 Financials are out.$0 revenue and $233K of deferred compensation. 😄CEO thanks the gullible shareholders for giving him a comfortable lifestyle and providing nothing back in return. 

CLERK'S DEFAULT JUDGMENT in favor of Robert J Nicoletta against Endonovo Therapeutics, Inc. It is hereby ORDERED, ADJUDGED AND DECREED: That for the reasons stated in the Court's Order dated April 16, 2026, the Court grants Nicoletta's request for default judgment, and the parties are directed to resolve the claims under the Promissory Note through arbitration administered by JAMS; accordingly, the case is closed.
--------
ORDER re:23 Proposed Order to Show Cause Without Emergency Relief, filed by Robert J Nicoletta. The underlying dispute between Robert Nicoletta and Endonovo Therapeutics Inc. ("Endonovo") stems from Endonovo's alleged violations of the Securities Act of 1933 and the Securities Exchange Act of 1934. See Doc. 2. Nicoletta alleges that, in 2022, Endonovo employed a broker who solicited Nicoletta's investment in a $100,000 promissory note, even though the broker was not registered to solicit or sell securities. Id. P 1. On June 24, 2022, in connection with Nicoletta's investment, Endonovo executed a promissory note (the "Promissory Note") in favor of Nicoletta and the parties executed a securities purchase agreement (the "SPA"). Id. P 11. Section 4.6 of the Promissory Note allows for arbitration, at Nicoletta's election, for disputes arising out of the Promissory Note: Any action brought by either party against the other arising out of or related to this Note, or any agreements between the parties shall be commenced only in the State of New York, County of Westchester or federal courts of general jurisdiction located in the Southern District of New York, except that all such disputes between the parties shall be subject to alternative dispute resolution through binding arbitration at the Holder's sole discretion and election Related [+]. As further set forth in this Order, Further, as the Promissory Note states that disputes shall be "subject to alternative dispute resolution through binding arbitration at the Holder's sole discretion and election," Doc. 2-1 at 13, it follows that Nicoletta, as holder of the Promissory Note, can elect to arbitrate the claims before JAMS. Accordingly, the Court grants Nicoletta's request for default judgment, and the parties are directed to resolve the claims under the Promissory Note through arbitration administered by JAMS. The Clerk of Court is respectfully directed to close the case. SO ORDERED.

No amount of pumping will get this off NO BID. They just wasted their money.  Their only hope is that a reverse split happens and then get out with a haircut. 😄

Look to a new group of pumpers to show up given the buying. This turd is dead and floating.

It doesn't even have assets in it yet millions in liabilities and millions in convertible debt to be converted. The Scummy CEO has stolen the assets into another company he controls and given himself a bunch of equity.

What assets would they even go after? They already sold the assets to themselves to screw over the shareholders. The best they can do is get stock in the new company.

If they can't get the R/S approved and cannot comply with the obligations of the lawsuit settlement....is it time for BK proceedings?

Upgraded to OTCID

Looks like the note holders are now dumping at $0.000001 since Collier couldn't get his 1-1,000 reverse split approved.

Don't forget the $10 million he will need to launch an OTC product.

Remember when IcyHot came out with their OTC tens device? They spent around $30 to $35 million to launch it.

Mayer doesn't have a product and investors don't really get excited about investing in reselling a product that has been out for years and has little to no traction/adoption.

The Biel board is reminiscent of the old Miller Lite commercials where 2 sides scream at each other and accomplish nothing.....tastes great...less filling. 😄
Only thing people can do is sit back and see what Electrome will eventually do. No point in creating fantasy scenarios. Also, when are initial projected timelines ever met in any field? Almost never. There will always be some hiccups that create delays. 

Thanks for this info. I got an older Assisi Loop that can be modified and I'm about to do it with the same little battery holders that you used, glued to the back. I'm going to jumper those tiny ON/OFF switches in the battery holders because they are so cheap that I think they will fail anyway, eventually. I used the same little battery holders on my hacked ActiPatches without jumping the switches, and those little switches are annoying, as you said.

I didn't realize how large and well-built the Assisi Loop is! Now I see why the Electrome people think the ActiPatch is just a toy as biotech_traderz said.

I'm taking a hiatus from the BIELiever board because those pumpers are over the top, talking about share buybacks, audits, OTCID, and 10x share price increases. They think Electrome's picture of a SofPulse-shaped device is an "updated ActiPatch" and they think Electrome is going to start testing the ActiPatch on the vagus nerve. The stupidity there is beyond belief.

After researching Electrome's pitch deck and communicating with Mayer, I believe that Electrome plans to license the ActiPatch for a year or three while they develop their "PAINKILLER" app which will use a SofPulse clone. Bioelectronics Corp might get $1 million gross revenues from this OEM licensing deal which won't be enough to do anything but barely survive for another few years. If the ActiPatch sells well, I think Mayer will pursue his own OTC clone, but for now, he plans to buy 100,000 units from Bioelectronics Corp who will get them manufactured in China.

Assuming it even happens! Mayer seems to be having a hard time raising money, as biotech_traderz suggested last year. Mayer wanted to launch ActiPatch in Q4 2025 and launch his new SofPulse in Q1 2026 but he's not even going to get the ActiPatch launched in Q1 2026 and I'm skeptical about seeing ActiPatch launched before Q3 2026. First Mayer needs a couple million $$$, THEN he needs to place the stocking order with Bioelectronics Corp for 100,000 units (costing about $1 million), then CICD Shenzhen needs to manufacture the devices, then Mayer needs to get them from China. Kelly Whelan said on FB that she won't release a PR until Mayer gives her some money, and since that PR is still MIA I don't think Mayer has given her a dime yet.

If it ever launches, it will be interesting to see how fast Mayer can sell that first 100,000 units. Other resellers couldn't sell 10,000 units in a year. Maybe Mayer will launch a blitzkrieg marketing campaign in the USA. If he does, it will be interesting to see how fast he can sell the SECOND lot of 100,000. The ActiPatch has a history of being "one and done," meaning customers buy one but don't return to buy more. Mayer's focus is on his PAINKILLER app and his platform of doctor-prescribed PEMF, not on reselling the low-power OTC ActiPatch which gets turned ON and left ON and doesn't need doctor supervision or input.

The difference is that when you are on Nasdaq you actually have to have an independent board of directors and voter have to approve those reverse splits. Here collier is the one and only board member and he gave himself 100x votes to do whatever he wants. That is why he is having problems now. No reporting, no assets, no board, yet still touting Nasdaq to fool investors.

Have you seen how many reverse splits, in such short time, MULN had while on the big boards? 😄.  That is one for the history books.

Pretty sure its the regulators that are not approving the reverse split.

Collier has pulled this scam multiple times now and he, like the pathetic idiot that he is, made the mistake of claiming it was to uplist the stock onto NASDAQ which is not happening given that the company is now essentially a shell. There are no assets. If you look up the patents that are still valid they have already been assigned to his other company SofPulse, yet there is nothing on the balance sheet to reflect this transaction.

ENDV should just increase the ratio from 1K to a higher amount. I wonder how much patience Trillium has as this sits stagnant with No Bid.

I am not sure about the auto cycle being the determining factor of the battery situation. I believe the auto cycle was a feature available before the redesign of the battery situation. I am aware of the redesign but have not researched it or tried hacking the newer version since I have 2 working older models.

is it possible that the "newer" and "older" Model 2.0 is really the Manual and Auto-Cycle versions?

Meaning... the Manual 2.0 can have the battery replaced, but the Auto-Cycle 2.0 cannot?

All I know at this point is that people online are saying that they successfully replaced the batteries in the "older" Model 2.0 but could not get it to work on the "newer" Model 2.0.

I do not know about 1 battery holder. I did try that initially but it did not work for me. I had the same thought process as you. I then just wired 2 separate CR battery holders with each going to the original battery lead locations. I have them side by side on the back of the module. Is low profile. I glued the cases to the back.The only "pain" is the CR cases have their own individual on/off switches so you have to be mindful of them to also be "on" if you wish to use the loop. After doing this modification, I have only tested it a few times. Cannot really comment on the battery life but it should be equivalent to an original unit.

only if the "dead" one is old enough to be modified. The NEWER "dead" ones are worthless because replacing the batteries doesn't reset the "low battery" flag in memory and doesn't revive the unit.

Assisi Loop Model 2.0 can be either older or newer. $100 for a newer Model 2.0 would be a waste of money. I'd pay maybe $20 to buy a dead one online. If I could see the thing in person I can tell if it's older or newer, but online it's hard to tell.

I modified my ActiPatches with external battery holders. It seems like it would be a little bulky to attach two of those to the outside of a SofPulse, but that's what I would probably try.

The batteries are connected in parallel so it's just 3vdc supply... if I put just one external battery holder on the outside, how long do you think it would last?

Even if you buy a "dead" one for $100 and replace the batteries, wouldn't it still be worth it rather than paying $300+ for a new one?
I have successfully replaced batteries in 2 older units. One of them I replaced the batteries directly inside. The other one, I actually attached an external battery holder for the CR batteries. Won't have to open the unit ever again. 😀

Anyone have an idea about where to buy or reclaim old SofPulse or Assisi Loop devices that have dead batteries? I assume that people just throw them away. I see some guy on eBay selling them but his feedback is terrible -- he's a scammer and he wants $100 apiece for dead ones.

I want to mess around with replacing the batteries in one. I've successfully done this with the ActiPatch -- now I want to try it with the SofPulse (Assisi Loop).

Apparently, the newest version of the Model 2.0 Assisi Loop has circuitry that permanently sets a "low battery" flag in memory, preventing the device from ever working again after the batteries run down. So I would need an older Model 2.0 or I'd need to figure out how to reset that flag.

Side question: anyone know how they set that permanent "battery low" flag? Is it in EEPROM or in a BIOS? That's kind of a clever trick. People must have been doing this a lot.

That would be hilarious to see it reverse split after a closing price of .000001. 😄Even a reverse split of 1,000 is not enough with .0001. They should revise the split ratio to a higher amount.

They either have pushback from regulators or they don't want to risk reversing the stock when it closes at 0.000001 and end up at par value.

Expect a pump scheme to get the PPS up before pulling the trigger on the R/S.

They have to R/S because they don't have enough shares authorized to pay back a lender that won a lawsuit.

Also, this company no longer has any assets in it. The PEMF technology has already been "sold" to the CEO's other company and it has now raised $200k on wefunder.

Read the financials!!!!They lost a lawsuit. To repay the settlement at .0001 would take billions of shares. There is no chance of a run as the plantiff would just dump their shares into any potential buying volume.ENDV has to enact the reverse split. ENDV has a long history of delays. 

If they cancel the reverse split, the price will rise significantly. It's not the first time an OTC company has canceled a reverse split and then started rising again after news broke. All of you who speak ill of ENDV might regret selling so cheaply at 0.0001.

ENDV was not on the daily list of symbol changes for Monday. Looks like the R/S has been extended to a later unknown date. 

I wonder if they are informing their new investors in sofpulse that they lost pretty much all their patents due to non-payment.

Collier is a scoundrel who's greed and incompetence has led to this technology never being developed. Not only that but his old team is developing a similar technology at two different companies. Electrome (Hagberg and his ex-CMO) and Electro Cellular Healthcare (Hagberg).

Reminder: Reverse Split is going to happen any day now. The latest it will happen will be on Friday the 30th and then Monday Feb. 2 trading under the new share structure with a large haircut. Trillium will be dumping shares as fast as they can to get their lawsuit settlement.

They are using a device developed by Electro Cellular Healthcare Solutions.

That company is owned by Herrick and its President is David Saloff. Who, was the President of Ivivi Health Sciences when I first invested. Him and Sean Hagberg are the ones behind both companies.

https://www.clinicaltrialsarena.com/news/device-headband-alzheimers-dementia/?cf-view

Sean Hagberg is a professor in the neurosurgery department at the University of New Mexico.

They are also evaluating the same technology for treating myocardial infarction at cedars sinai.

https://researchers.cedars-sinai.edu/Aakriti.Gupta/grants

As I previously stated I know a lot of people involved in this space at multiple companies. The device they are using is a new variant of the SofPulse as pointed out by the patent granted to the Herrick company and Sean Hagberg. The signal from the Sofpulse device is on the order of 10x stronger than the ActiPatch. That is why it is prescription only.

Nice DD! I found two Herrick clinical trials on clinicaltrials.gov for PEMF: Alzheimers and Dementia, one in Miami, one in Hackensack NJ

Neither is using an FDA-cleared device. Might be Electrome's uncleared new device. Same study protocol for each: "They will treat themselves at home three times a day for 15 minutes" which is pretty close to the directions for SofPulse.

https://clinicaltrials.gov/study/NCT06862557
https://clinicaltrials.gov/study/NCT05295615

Google Sean Hagberg. Electrome is listed on his LinkedIn.

Speaking of parents, you had posted a link referring to a patent owned by the Herrick company. I know Sean Hagberg is working with them on some clinical trials. I figured he must be using the Sofpulse or some close variation of it. Will be interesting to see what results they come up with the various trials they are doing. The interesting thing is they are doing these trials with private money. They don't seem interested in being a public company. 
You had mentioned Electrome and Dr. Zubcevik. They are not associated with Herrick and Hagberg from what I see. Are they working together with Herrick? Or is Hagberg working with both entities independently?

Just another garbage play by a pumping fool

You took the time to type out that FAIRYTALE, SO SAD!!!!!

You need to get a life, SO SAD!

ENDV=BIEL=💩

LOL. What a clown. Try some due diligence first.

No more assets in this company. In fact the patents they stole from the company have expired because they couldn't afford to pay for the maintenance fees.

Patent covering the SofPulse device and its use for post-surgical pain has expired, see below:
https://patents.google.com/patent/US9415233B2/en

Patent covering the use of the technology for treating neurological conditions such as stroke has also expired:
https://patents.google.com/patent/US10426967B2/en?inventor=Arthur+A.+Pilla

They literally have no assets and just a bunch of debt to be converted as well as a 1-1,000 reverse split that was just announced.

buy buy 14 milion.
💥🚀💵💲

LOL, The float hasn't been updated in over a year little buddy.

If you have been paying attention you would also know that the company doesn't have any patents anymore, it has sold them to another company controlled by the crook CEO. Also, they just announced a 1-1,000 reverse stock split. There is a reason this is trading at par value, it is worthless.

Lastly, try looking up some of those patents you referenced, many of them have expired because the company didn't pay the fees.

It's a very small float, and if this gets out in the news, it'll go viral. If you look at the patents on the company's website, this is a bargain price.
💥🚀💵

Looks like they already completed the sale of the patents to SofPulse, Inc. They just didn't tell the shareholders. I wonder why?

https://patents.google.com/patent/US9427598B2/en?inventor=Arthur+A.+Pilla

The patents have already been assigned to Sofpulse going back to July of 2024. My question is why not announce it? To me it is now crystal clear. They didn't announce it because they want to keep the ability of the debt holders to convert their shares and dump it into the bids on unsuspecting bag holders. Now we know why they haven't reported any revenue. It is because the revenue is being reported into the new company because ENDV no longer has any assets. If the patents have been assigned to Sofpulse for nearly a year and a half then ENDV should show an asset on the balance sheet. Either a Seller note or stock in the new company. Yet neither is present in the balance sheet.

This is getting to the point where the SEC and the FBI should investigate these clowns for fraud.

I think collier is destroying it on purpose to personally enrich himself.

He now markets himself as the CEO of SofPulse not ENDV, which tells you all you need to know.

Back on Jan 29, I made 3 predictions in the following post: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175733988

1 and 3 have come true but the second is still to come. I predicted Collier would give himself a massive bonus when the stock went below par value but I now believe he will do that right before he steals the assets from the company and puts them into SofPulse. That is why he has so much deferred compensation, which he will conveniently convert into stock at probably par value. He will also give himself a massive stock bonus that makes Elon Musk look like a choir boy. Stay tuned this is going to only get worse.

BUYER BEWARE: New Target Stock Price is $0.0001

Given that Trillium has the ability to convert at 50% discount to market their next conversions will be at $0.0001 or par value. As was predicted in my post below, the market price converges toward the conversion price and following conversions is driven down 50%, essentially it is a death spiral.

My other warning is that this company only has 2.5 billion authorized shares and is already at north of 800 million shares before we get conversions. I also want to point out that I have a very strong hunch that the CEO will give himself a massive bonus in the form of shares as soon as the stock price reaches par value ($0.0001). I predict somewhere in the neighborhood of $50,000 of stock at par value or 500 million shares before he decides to reverse the stock and repeat this scam as he has already done this to shareholders.

So my warning and predictions are as follows:

1.) Stock price goes to $0.0001 or less
2.) CEO gives himself a large bonus at par value or less (maybe 500 million shares)
3.) Reverse stock split at 1 for 1,000 like the last time.

You have been warned. Please feel free to post this as a sticky.

Whoever bought .0001 on a gamble will now be stuck on NO BID until after the reverse split is enacted. This will fall immediately after the reverse split. The plantiff of the lawsuit will be happy to be able to dump their shares more easily after the split.

BUYER BEWARE: ENDV ANNOUNCES 1-1,000 REVERSE SPLIT!!! RUN!!!

https://www.otcmarkets.com/file/company/financial-report/513673/content

They no longer even bother to care about the business or shareholders.

They are fully concentrated on getting another shot at the goal by stealing the assets out of the company and suckering another set of investors into buying out the debt they took out to fund their lifestyles for the last 5 years.

Q3 ER is out. $0 sales in the Q. $0 sales all year. 😄

If anyone wants to see how deceptive ENDV is with investors, just look at this investor solicitation page.
www.invest-endv.com

They show a market cap of $4 million as of Sept. 2023. But now their market cap is $181,000.
The promote an increase of market cap of 281% for a time period between 2022 and 2023. It has completely bottomed out now.
The real kicker is showing a valuation of $75 million based on an independent study done in 2018. The site was created in 2023/2024. They should have at least used an updated valuation. They did not because they knew it would be significantly less.

New O/S is 1.8 billion. R/S is now imminent.